Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
Wolfs
T F
TF
Department of Virology, University of Amsterdam, The Netherlands.
Nara
P L
PL
Goudsmit
J
J
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology / Q000382:microbiology* / Q000517:prevention & control; D000595:Amino Acid Sequence; D000940:Antigenic Variation / Q000235:genetics*; D005814:Genes, Viral; D005838:Genotype; D015483:HIV Antibodies / Q000276:immunology; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology; D015497:HIV-1 / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D016086:Lentivirus / Q000145:classification / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D010641:Phenotype; D010802:Phylogeny; D012190:Retroviridae / Q000235:genetics; D015302:Simian Immunodeficiency Virus / Q000235:genetics; D014611:Vaccination; D014774:Virulence
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments